Xarelto Lawsuit Update: 40 Cases To Be Selected For Bellwether Trials

March 22, 2016 – – BloodThinnerHelp.com reports on an update to MDL No. 2592 indicating that 40 cases will be chosen for the Xarelto bellwether pool. According to an order issued by presiding Judge Eldon E. Fallon, both the defense and the plaintiffs will have the opportunity to select 10 cases to be included in the discovery pool and 20 more cases will be selected randomly and proportionally to each state.

The order indicates that five plaintiffs will be selected by plaintiffs and five plaintiffs will be selected by the defense in the Eastern District of Louisiana with ten plaintiffs selected randomly. Mississippi plaintiffs will be determined after one plaintiff is selected by the defense and one is selected by plaintiffs, with two selected randomly. For Texas, one plaintiff will be selected by plaintiffs and one will be selected by the defense. Plaintiffs will then be able to choose 7 states in which five plaintiffs will be selected by the plaintiffs and 2 plaintiffs will be selected randomly. The same opportunity will be given to the defense, according to the order.

A multidistrict litigation panel was created in 2014 in Eastern Louisiana for the efficient management of cases. Since its creation, MDL No. 2592 has reached almost 3,000 cases in which plaintiffs allege that using the blood-thinning drug Xarelto caused them negative side effects. Many individuals filing cases claim that manufacturers, Bayer AG and Johnson & Johnson, did not adequately warn them about the possibility of adverse side effects such as gastrointestinal bleeding, brain hemorrhages, internal bleeding, rectal bleeding, pulmonary embolisms (blood clots in the lung), epidural hematoma, stroke, and heart attacks. The first bellwether trials are expected to begin in February 2017.

As bellwether trial dates approach, Attorney Joseph Osborne is working to ensure that those who believe they have been negatively affected by the drug are able to explore their legal rights. Those individuals may be entitled to legal action and substantial financial compensation. Osborne is currently offering free legal consultations to qualifying parties.

For more information, or to ask questions about Xarelto, contact Joseph Osborne, Esq. by call (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008803